Results 41 to 50 of about 6,619,911 (229)

IgA mediated anti-glomerular basement membrane disease with associated circulating anti-neutrophil cytoplasm antibodies [PDF]

Journal of Nephropathology
Anti-glomerular basement membrane (anti-GBM) disease is an aggressive small vessel vasculitis usually mediated by IgG autoantibodies. We describe the case of a 73-year-old male with rapidly progressive renal failure that was diagnosed with IgA mediated ...
Patricia Alves, Mário Góis, Tiago Pereira, Dulce Carvalho, Fernando Nolasco   +4 more
doaj   +1 more source

Long-term outcome of anti-glomerular basement membrane antibody disease treated with immunoadsorption. [PDF]

PLoS ONE, 2014
Anti-glomerular basement membrane (GBM) antibody disease may lead to acute crescentic glomerulonephritis with poor renal prognosis. Current therapy favours plasma exchange (PE) for removal of pathogenic antibodies.
Peter Biesenbach, Renate Kain, Kurt Derfler, Thomas Perkmann, Afschin Soleiman, Alexandra Benharkou, Wilfred Druml, Andrew Rees, Marcus D Säemann   +8 more
doaj   +1 more source

Anti-Glomerular Basement Membrane Disease [PDF]

, 2018
Anti–glomerular basement membrane (GBM) disease often presents with rapidly progressive glomerulonephritis with or without lung hemorrhage. It is rare to present with lung hemorrhage alone.
Kavita Gulati, Gulati, Kavita, McAdoo, Stephen P, Stephen P. McAdoo   +3 more
core   +1 more source

Atypical Antiglomerular Basement Membrane Disease in a Pregnant Patient with Systemic Lupus Erythematosus

Case Reports in Nephrology, 2023
Antiglomerular basement membrane disease (anti-GBM) is an unusual cause of glomerulonephritis. Patients usually present with rapidly progressive glomerulonephritis with or without pulmonary hemorrhage.
Areerat Ounhasuttiyanon, Ngoentra Tantranont, Thatsaphan Srithongkul   +2 more
doaj   +1 more source

Clinicopathological characteristics and predictors of poor outcome in anti-glomerular basement membrane disease – a fifteen year single center experience

Renal Failure, 2021
Introduction Anti-glomerular basement membrane (anti-GBM) disease is a small vessel vasculitis affecting the renal and lung capillary beds. We aim to study the clinicopathological characteristics and predictors of poor outcome of this disease in our ...
Zafirah Zahir, Asif Sadiq Wani, Narayan Prasad, Manoj Jain   +3 more
doaj   +1 more source

The Immunobiological Agents for Treatment of Antiglomerular Basement Membrane Disease

Medicina, 2023
Combination therapy with glucocorticoids, cyclophosphamide, and plasmapheresis is recommended as the standard treatment for anti-glomerular basement membrane (anti-GBM) disease, but the prognosis of this disease remains poor.
Marina Yamashita, Mamiko Takayasu, Hiroshi Maruyama, Kouichi Hirayama   +3 more
doaj   +1 more source

Goodpasture’s Syndrome with Negative Anti-glomerular Basement Membrane Antibodies

European Journal of Case Reports in Internal Medicine, 2017
A young male patient with rapidly progressive and life-threatening pulmonary haemorrhage due to anti-glomerular basement membrane (anti-GBM) antibody disease without renal involvement repeatedly tested negative for serum anti-GBM antibodies.
Tjitske Berends-De Vries, Susan Boerma, Joan Doornabal, Bert Dikkeschei, Coen Stegeman, Thiemo Veneman   +5 more
doaj   +1 more source

The clinical and immunological features of the post-extracorporeal shock wave lithotripsy anti-glomerular basement membrane disease

Renal Failure, 2021
Introduction Extracorporeal shock wave lithotripsy (ESWL) is a noninvasive modality to treat urolithiasis, with complications including tissue damage and hematoma of kidney parenchyma.
Beining Wang, Jia Xiaoyu, Xiaojuan Yu, Zhao Cui, Minghui Zhao   +4 more
doaj   +1 more source

Anti-glomerular basement membrane disease mediated by IgG and IgA: a case report

Renal Failure, 2021
Background Anti-glomerular basement membrane (anti-GBM) disease is a rare autoimmune condition responsible for rapidly progressive glomerulonephritis. This disease is usually mediated by IgG autoantibodies against the noncollagenous domain of the α3(IV ...
Guming Zou, Haitao Lu, Li Zhuo, Wanzhong Zou, Wenge Li   +4 more
doaj   +1 more source

Co-injection of anti-HS antibodies in anti-GBM-induced glomerulonephritis differentially affects glomerular PMN and macrophage influx.

, 2021
Glomerular PMN influx after (A) 2 hours, (B) 1 day and (C) 4 days, and glomerular macrophage influx after (D) 2 hours, (E) 1 day and (F) 4 days analyzed by immunofluorescence staining. Results are expressed as means ± s.e.m. from four mice in each group.
Toin H. van Kuppevelt (10013111), Nathalie J. H. G. Passmann (11873757), Markus A. Loeven (3368984), Jasper J. van Gemst (3368987), Bart Smeets (170582), Johan van der Vlag (45996), Jo H. Berden (11873763), Ton J. Rabelink (8695392), Angelique L. W. M. M. Rops (11873760)   +8 more
core   +1 more source